Mebias Discovery, Inc Employee Directory

Biotechnology ResearchPennsylvania, United States2-10 Employees

MEBIAS holds a game-changing platform to discover next generation,  GPCR drugs devoid of on-target side effects.

G-protein Coupled Receptor (GPCR) therapeutics comprise ~30% of current prescribed drugs. Mebias’ understanding of protein dynamics of GPCRs offers a unique advantage.  Given our experience and access to two key technologies – native GPCR purification and protein nuclear magnetic resonance – our approach offers resolution to identify agonists that is lacking in other methodologies.  We have delivered a series of biased mu opioid receptor scaffolds among which is an  clinical stage compound.  The Mebias platform significantly decreases the time and costs to deliver optimized leads.

Our initial areas of focus are CNS/Pain, OUD, Metabolic, and Inflammatory related disorders.


Expertise / Assets
  • Rapid identification and optimization of IND candidates devoid of on-target adverse effects, enabled by a fully validated assay suite which identifies ligand-induced dynamic conformation of GPCR signaling.
  • Differentiated mu-opioid receptor agonist (MEB-1170) for the treatment of OUD and pain (lacking respiratory depression/GI motility issues/tolerance and does not demonstrate potential for abuse liability)
Business Proposal
  • Seeking co-development and/or license our mu-opioid drug candidates 
  • Research funding/collaboration for lead discovery of additional targets in selected disease areas

Find Mebias Discovery, Inc employees' phone numbers or email addresses

Mebias Discovery, Inc Global Highlights

Location
Employees

North America
4

Minus sign iconPlus sign icon
  • United States Of America
    4

Mebias Discovery, Inc's Leadership

  • Stylized image of a person
    S. R.
    Chief Medical Officer
    Phone icon
  • Stylized image of a person
    L. C. K.
    President And Co-Founder
    Phone icon
  • Stylized image of a person
    B. T.
    Managing Partner
    Phone icon
  • Stylized image of a person
    S. B.
    Managing Partner
    Phone icon

Contact profiles from Mebias Discovery, Inc

Name
Title
Contact Info
Location
Last Update
  • Stylized image of a person
    B. T.
    Managing Partner
    Phone icon
    Nov 17, 2025
  • Stylized image of a person
    S. B.
    Managing Partner
    Phone icon
    United StatesConnecticut
    Sep 12, 2025
  • Stylized image of a person
    L. C. K.
    President And Co-Founder
    Phone icon
    United StatesMississippi
    Sep 26, 2025
  • Stylized image of a person
    S. R.
    Chief Medical Officer
    Phone icon
    May 29, 2025

Frequently Asked Questions

What is Mebias Discovery, Inc known for?

Minus sign iconPlus sign icon
Mebias Discovery, Inc was founded in 2015 operates in the Biotechnology Research industry. The company's main headquarters is located in 3001 Market Street, Suite 140. Explore Mebias Discovery, Inc's company overview page for more information.

What is Mebias Discovery, Inc's most common email format?

Minus sign iconPlus sign icon
Mebias Discovery, Inc employees' email format typically follows the pattern of . Trying to find reliable and up-to-date employee contact data? Find more Mebias Discovery, Inc email formats with LeadIQ.

How many employees does Mebias Discovery, Inc have currently?

Minus sign iconPlus sign icon
Mebias Discovery, Inc has approximately 4 employees as of December 2025. These team members are located across 1 continents, including North America.

Who are Mebias Discovery, Inc's key employees and leadership?

Minus sign iconPlus sign icon

As of December 2025, Mebias Discovery, Inc's key employees include:

  • Chief Medical Officer: S. R.
  • President And Co-Founder: L. C. K.
  • Managing Partner: B. T.
  • Managing Partner: S. B.

Looking for contact data? Unlock accurate emails and phone numbers for your ideal prospects with LeadIQ.

Ready to create more pipeline?

Get a demo and discover why thousands of SDR and Sales teams trust
LeadIQ to help them build pipeline confidently.

© LeadIQ, Inc. All rights reserved.